ARCHIVES

Clinical Biomarker Discovery Initiative would speed progress in early detection and measurement of response to therapy, Leland Hartwell tells NCI.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

GSK HPV Vaccine Offers Protection From 4 HPV Types

April 27, 2007

Latest U.S. cancer statistics cover 84% of population.

December 5, 2003

Frei, Freireich Share One GM Prize; Ames, Erikson Win Others

June 17, 1983

NCAB Votes To Return P01 Review To Pre-1987 System, Two-Tier Review

May 14, 1993

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

NCI Progress: Biomarker Labratories Funded To Develop Early Detection Methods

October 22, 1999